Advanced Search

    column
    The Exploration Course of Postoperative Radiotherapy for Stage Ⅲ N2 Non-Small Cell Lung Cancer
    LIANG Jun
    2020, 20(6): 321-324. DOI: 10.12019/j.issn.1671-5144.2020.06.001
    Abstract PDF
    Effect of Precise Postoperative Radiotherapy on Survival and Failure Mode of pⅢA-N2 Non-Small Cell Lung Cancer Patients After Complete Resection and Adjuvant Chemotherapy
    ZHU Xiao-xia, SU Jun-wei
    2020, 20(6): 325-328. DOI: 10.12019/j.issn.1671-5144.2020.06.002
    Abstract PDF
    Radiation Therapy in Stage Ⅰ~Ⅱ Non-Small Cell Lung Cancer After R0-Resection: An Analysis Based on the National Cancer Data Base
    XIONG Le, LIU An-wen, LIU Ke-jun
    2020, 20(6): 329-332. DOI: 10.12019/j.issn.1671-5144.2020.06.003
    Abstract PDF
    No Survival Benefit of Adjuvant Conformal Radiotherapy in N2 Non-Small Cell Lung Cancer
    PAN Yi, XU Jing-yan
    2020, 20(6): 333-335. DOI: 10.12019/j.issn.1671-5144.2020.06.004
    Abstract PDF
    The Value of Combined Detection of Lp-PLA2, RBP, Hcy and ox-LDL in Serum for the Diagnosis and Prognosis of Acute Coronary Syndrome Patients Under 50 Years Old
    ZHANG Jing, HE Zhi-an
    2020, 20(6): 336-343. DOI: 10.12019/j.issn.1671-5144.2020.06.005
    Abstract PDF
    Clinical Analysis of Ataxia as Major Performance in the Dystrophy Neuropathy Cases Following Allogeneic Hematopoietic Stem Cell Transplantation
    HUANG Li-si, WU Sui-jin, WENG Jian-yu, LUO Cheng-wei, ZHAO Jie-hao, HUANG Biao, LING Wei, HUANG Xin, LAI Pei-long, ZENG Xiang-you, DU Xin
    2020, 20(6): 344-350. DOI: 10.12019/j.issn.1671-5144.2020.06.006
    Abstract PDF
    Observation and Nursing for Adverse Reactions of PD-1 Inhibitor Combined With Locoregional Therapy for the Treatment of Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus
    ZHANG Ju-hua, CHEN Long, LIU Yu-jie, TIAN Su-qing
    2020, 20(6): 351-356. DOI: 10.12019/j.issn.1671-5144.2020.06.007
    Abstract PDF
    The Value of Ultrasound in Evaluating the Efficacy of Neoadjuvant Chemotherapy in Early,Middle and Late Stages for ER Negative Breast Cancer
    GUO Yu-ping, PEI Shu-fang, CONG Shu-zhen, LIANG Zhao-qiu, JIANG Xiao-yan
    2020, 20(6): 357-362. DOI: 10.12019/j.issn.1671-5144.2020.06.008
    Abstract PDF
    Preliminary Study of the Source of Regulatory T Cells at the Maternal-Fetal Interface
    LIN Wen, YAO Jing-xin, LI Zheng-juan
    2020, 20(6): 363-373. DOI: 10.12019/j.issn.1671-5144.2020.06.009
    Abstract PDF
    Look at the Immune Therapy From the Perspective of PD-L2
    ZHANG Xu-chao
    2020, 20(6): 374-379. DOI: 10.12019/j.issn.1671-5144.2020.06.010
    Abstract PDF
    Some Thoughts on the Treatment of a Double Primary Tumor in the Immune Era
    LIN Hui, PAN Yi
    2020, 20(6): 380-384. DOI: 10.12019/j.issn.1671-5144.2020.06.011
    Abstract PDF